Clinical Trial Search Results for "TIMI 2A"
Braunwald, E., Knatterud, G. L., Passamani, E. R., Robertson, T. L. Announcement of protocol change in thrombolysis in myocardial infarction trial Journal of the American College of Cardiology. 1987;9(2):467.
Braunwald, E., Knatterud, G. L., Passamani, E., Robertson, T. L., Solomon, R. Update from the Thrombolysis in Myocardial Infarction Trial Journal of the American College of Cardiology. 1987;10(4):970.
Passamani, E., Hodges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., et al., The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1987;10(5 Suppl 2):51B-64B. Abstract
Williams, D. O., Ruocco, N. A., Forman, S. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1987;10(5 Suppl B):45B-50B. Abstract
Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group JAMA. 1988;260:2849-58. Abstract
Chaitman, B. R., Thompson, B., Wittry, M. D., Stump, D., Hamilton, W. P., Hillis, L. D., Dwyer, J. G., Solomon, R. E., Knatterud, G. L. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators Journal of the American College of Cardiology. 1989;14(5):1159-65. Abstract
Rogers, W. J., Bourge, R. C., Papapietro, S. E., Wackers, F. J., Zaret, B. L., Forman, S., Dodge, H. T., Robertson, T. L., Passamani, E. R., Braunwald, E., et al., Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study American journal of cardiology. 1989;63(9):503-12. Abstract
Baim, D. S., Braunwald, E., Feit, F., Knatterud, G. L., Passamani, E. R., Robertson, T. L., Rogers, W. J., Solomon, R. E., Williams, D. O. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives Journal of the American College of Cardiology. 1990;15(5):1188-92. Abstract
Chaitman, B. R., Thompson, B. W., Kern, M. J., Vandormael, M. G., Cohen, M. B., Ruocco, N. A., Solomon, R. E., Braunwald, E. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators American heart journal. 1990;119(2 Pt 1):213-23. Abstract
Rogers, W. J., Baim, D. S., Gore, J. M., Brown, B. G., Roberts, R., Williams, D. O., Chesebro, J. H., Babb, J. D., Sheehan, F. H., Wackers, F. J., et al., Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation. 1990;81(5):1457-76. Abstract
Truong, Q. A., Cannon, C. P., Zakai, N. A., Rogers, I. S., Giugliano, R. P., Wiviott, S. D., McCabe, C. H., Morrow, D. A., Braunwald, E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial Am Heart J. 2009;157(4):673-9 e1. Abstract
SEARCH BY:
For more information about enrolling in a clinical trial, participating in a clinical trial, or starting a new clinical trial contact smchale@partners.org or 617.278.0145.